UBS Maintains Buy on American Healthcare REIT, Lowers Price Target to $62
UBS analyst Michael Goldsmith maintains American Healthcare REIT (NYSE:AHR) with a Buy and lowers the price target from $63 to $62.
Stocks · News reference
Raymond James Initiates Coverage On American Healthcare REIT with Strong Buy Rating, Announces Price Target of $62
Raymond James analyst David Rodgers initiates coverage on American Healthcare REIT (NYSE:AHR) with a Strong Buy rating and announces Price Target of $62.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Barclays Maintains Overweight on American Healthcare REIT, Lowers Price Target to $60
Barclays analyst Richard Hightower maintains American Healthcare REIT (NYSE:AHR) with a Overweight and lowers the price target from $66 to $60.
This Electra Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Analysts initiated coverage on NHP (Outperform, $20), OIG (Buy, $13), ETRA (Overweight), AHR (Strong Buy, $62).